AAAAAA
Results:
1-7
|
Results: 7
Authors:
Eddershaw, PJ
Beresford, AP
Bayliss, MK
Citation: Pj. Eddershaw et al., ADME/PK as part of a rational approach to drug discovery, DRUG DISC T, 5(9), 2000, pp. 409-414
Authors:
Spalding, DJM
Harker, AJ
Bayliss, MK
Citation: Djm. Spalding et al., Combining high-throughput pharmacokinetic screens at the hits-to-leads stage of drug discovery, DRUG DISC T, 5(12), 2000, pp. S70-S76
Authors:
Bayliss, MK
Little, D
Mallett, DN
Plumb, RS
Citation: Mk. Bayliss et al., Parallel ultra-high flow rate liquid chromatography with mass spectrometric detection using a multiplex electrospray source for direct, sensitive determination of pharmaceuticals in plasma at extremely high throughput, RAP C MASS, 14(21), 2000, pp. 2039-2045
Authors:
Cross, DM
Bayliss, MK
Citation: Dm. Cross et Mk. Bayliss, A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development, DRUG METAB, 32(2), 2000, pp. 219-240
Authors:
Carlile, DJ
Hakooz, N
Bayliss, MK
Houston, JB
Citation: Dj. Carlile et al., Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans, BR J CL PH, 47(6), 1999, pp. 625-635
Authors:
Bayliss, MK
Bell, JA
Jenner, WN
Park, GR
Wilson, K
Citation: Mk. Bayliss et al., Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man, XENOBIOTICA, 29(3), 1999, pp. 253-268
Authors:
Bowers, GD
Bayliss, MK
Donnelly, MC
Fellows, I
Ismail, IM
Mookherjee, CR
Citation: Gd. Bowers et al., The characterisation of the major metabolite of salmeterol in the dog, J PHARM B, 18(3), 1998, pp. 461-470
Risultati:
1-7
|